These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 4310231)
61. Endotoxin attacks the cardiovascular system: black death at the tollgate. Lew WY J Am Coll Cardiol; 2003 Nov; 42(9):1663-5. PubMed ID: 14607456 [No Abstract] [Full Text] [Related]
62. Studies on the mechanism of potentiation of arteriolar constriction by dexamethasone in vivo. Darke AC Microvasc Res; 1975 May; 9(3):317-23. PubMed ID: 1128283 [No Abstract] [Full Text] [Related]
63. [Evaluation of usefulness of octapressin in stomatological procedures]. JaĆczuk Z; Gondzik W; Grabowska K; Malinowski J; Mojseowicz K Czas Stomatol; 1967 Dec; 20(12):1257-61. PubMed ID: 5235552 [No Abstract] [Full Text] [Related]
64. Decreased vasoconstrictor response to angiotensin II in the presence of vascular stenosis. Stock J; Wolf G J Clin Pharmacol; 1974 Jan; 14(1):17-24. PubMed ID: 4358347 [No Abstract] [Full Text] [Related]
65. Continuous recording of changes in mesenteric blood volume. Mullins GL; Guntheroth WG Ultrasonics; 1966 Jan; 4():24-5. PubMed ID: 5933520 [No Abstract] [Full Text] [Related]
66. Effect of hypokalemia and hypomagnesemia produced by hemodialysis on vascular resistance in canine skeletal muscle: role of potassium in active hyperemia. Anderson DK; Roth SA; Brace RA; Radawski D; Haddy FJ; Scott JB Circ Res; 1972 Aug; 31(2):165-73. PubMed ID: 5049734 [No Abstract] [Full Text] [Related]
67. The effects of angiotensin on renal vascularity in dogs. Elkin M; Meng CH Am J Roentgenol Radium Ther Nucl Med; 1966 Dec; 98(4):927-34. PubMed ID: 4288508 [No Abstract] [Full Text] [Related]
68. [Relations between sodium metabolism of the erythrocytes and vascular reactibility in normotensive subjects with a family history of hypertension]. Wessels F; Losse H Klin Wochenschr; 1967 Aug; 45(16):850. PubMed ID: 4298619 [No Abstract] [Full Text] [Related]
69. Differences in pericyte contractile function in rat cardiac and skeletal muscle microvasculatures. Tilton RG; Kilo C; Williamson JR; Murch DW Microvasc Res; 1979 Nov; 18(3):336-52. PubMed ID: 537511 [No Abstract] [Full Text] [Related]
70. Some properties of a high molecular vasopressor substance generated in human serum by incubation. Wurm H; Kenner T Basic Res Cardiol; 1978; 73(1):1-9. PubMed ID: 656013 [No Abstract] [Full Text] [Related]
72. [Relationship between the tonus of the canine mesenteric vascular bed and its sensitivity to various vasoconstrictor agents]. Stolc S Bratisl Lek Listy; 1969; 52(3):303-14. PubMed ID: 4310231 [No Abstract] [Full Text] [Related]
73. Antagonism of vasoconstrictor responses by exercise in the gracilis muscle of the dog. Burcher E; Garlick D J Pharmacol Exp Ther; 1973 Oct; 187(1):78-85. PubMed ID: 4355661 [No Abstract] [Full Text] [Related]
74. Differential effects of prostaglandins E 1 , E 2 , F 1 and F 2 on adrenergic vasoconstriction in the dog hindpaw. Kadowitz PJ; Sweet CS; Brody MJ J Pharmacol Exp Ther; 1971 Jun; 177(3):641-9. PubMed ID: 4328021 [No Abstract] [Full Text] [Related]
75. Mechanism of vascular resistance changes produced in skin and muscle by halothane. Akester JM; Brody MJ J Pharmacol Exp Ther; 1969 Dec; 170(2):287-93. PubMed ID: 4311321 [No Abstract] [Full Text] [Related]
76. A new pressor agent of renal origin: its differentiation from renin and angiotensin. Grollman A; Krishnamurty VS Am J Physiol; 1971 Nov; 221(5):1499-506. PubMed ID: 4330896 [No Abstract] [Full Text] [Related]